I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Schlingensiepen, K.
26
results:
Search for persons
X
Format
Online (25)
Print (1)
Mediatypes
Books (1)
Articles (Online) (22)
OpenAccess-fulltext (3)
Languages
german (1)
english (25)
Sorted by: Relevance
Sorted by: Year
?
1
8714 Trabedersen (AP 12009) in recurrent or refractory high..:
Bogdahn, U.
;
Mahapatra, A.K.
;
Suri, A.
...
European Journal of Cancer Supplements. 7 (2009) 2 - p. 497-498 , 2009
Link:
https://doi.org/10.1016/..
?
2
Targeted tumor therapy with the TGF-β2 antisense compound A..:
SCHLINGENSIEPEN, K
;
SCHLINGENSIEPEN, R
;
STEINBRECHER, A
...
Cytokine & Growth Factor Reviews. 17 (2006) 1-2 - p. 129-139 , 2006
Link:
https://doi.org/10.1016/..
?
3
450 The TGF-beta1 antisense oligonucleotide AP 11014 for th..:
Schlingensiepen, K.
;
Bischof, A.
;
Egger, T.
...
European Journal of Cancer Supplements. 2 (2004) 8 - p. 134 , 2004
Link:
https://doi.org/10.1016/..
?
4
439 TGF-beta2 suppression by the antisense oligonucleotide ..:
Schlingensiepen, K.
;
Hau, P.
;
Brawanski, A.
...
European Journal of Cancer Supplements. 2 (2004) 8 - p. 131-132 , 2004
Link:
https://doi.org/10.1016/..
?
5
449 Treatment of pancreatic cancer by TGF-beta2 suppression..:
Stauder, G.
;
Bischof, A.
;
Egger, T.
...
European Journal of Cancer Supplements. 2 (2004) 8 - p. 134 , 2004
Link:
https://doi.org/10.1016/..
?
6
359 Effect of the TGF-beta 2 specific antisense oligodeoxyn..:
Jaschinski, F.
;
Kielmanowicz, M.
;
Rothhammer, T.
..
European Journal of Cancer Supplements. 8 (2010) 7 - p. 113-114 , 2010
Link:
https://doi.org/10.1016/..
?
7
530 Activity of the TGF-beta 2 specific antisense oligodeox..:
Jaschinski, F.
;
Lang, S.A.
;
Moser, C.
...
European Journal of Cancer Supplements. 8 (2010) 7 - p. 169 , 2010
Link:
https://doi.org/10.1016/..
?
8
Targeted therapy for high-grade glioma with the TGF- 2 inhi..:
Bogdahn, U.
;
Hau, P.
;
Stockhammer, G.
...
Neuro-Oncology. 13 (2010) 1 - p. 132-142 , 2010
Link:
https://doi.org/10.1093/..
?
9
1259 Trabedersen (AP 12009) in the treatment of pancreatic ..:
Oettle, H.
;
Hilbig, A.
;
Seufferlein, T.
...
European Journal of Cancer Supplements. 7 (2009) 2 - p. 138 , 2009
Link:
https://doi.org/10.1016/..
?
10
329 POSTER A phase llb study in patients with recurrent mal..:
Bogdahn, U.
;
Zaaroor, M.
;
Parfenov, V.
...
European Journal of Cancer Supplements. 4 (2006) 12 - p. 103 , 2006
Link:
https://doi.org/10.1016/..
?
11
820 TGF-beta1 suppression by the antisense oligonucleotide ..:
Jachimczak, P.
;
Schlingensiepen, K.-H.
;
Schlingensiepen, R.
...
European Journal of Cancer Supplements. 1 (2003) 5 - p. S246 , 2003
Link:
https://doi.org/10.1016/..
?
12
34 The TGF-beta2 antisense ollgonucleotide ap 12009 as a th..:
Hau, P.
;
Bogdahn, U.
;
Schlaier, J.
...
European Journal of Cancer Supplements. 1 (2003) 5 - p. S14 , 2003
Link:
https://doi.org/10.1016/..
?
13
Reduction of erbB2 Gene-Product in Mamma Carcinoma Cell Lin..:
Bertram, J.
;
Killian, M.
;
Brysch, W.
..
Biochemical and Biophysical Research Communications. 200 (1994) 1 - p. 661-667 , 1994
Link:
https://doi.org/10.1006/..
?
14
Autoinduction of Platelet Derived Growth Factor (PDGF) A-Ch..:
Behl, C.
;
Bogdahn, U.
;
Winkler, J.
...
Biochemical and Biophysical Research Communications. 193 (1993) 2 - p. 744-751 , 1993
Link:
https://doi.org/10.1006/..
?
15
Inhibition of bFGF and several IEG's by antisense oligodeox..:
Gerdes, W.
;
Schlingensiepen, K.H.
;
Brysch, W.
.
Neurochemistry International. 21 (1992) - p. A7 , 1992
Link:
https://doi.org/10.1016/..
1-15